Samik Pharmaceutical Company LTD. (KOSDAQ:014950)
South Korea · Delayed Price · Currency is KRW 5,800.00
-130.00 (-2.19%)
At close: Jun 10, 2026
KOSDAQ:014950 Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Net Income | -703.66 | -754.89 | 3,522 | 2,969 |
Depreciation & Amortization | 1,346 | 1,376 | 1,351 | 1,278 |
Loss (Gain) From Sale of Assets | -45.48 | -45.98 | -9.5 | -0.07 |
Asset Writedown & Restructuring Costs | - | - | 23.8 | - |
Loss (Gain) From Sale of Investments | -306.51 | -348.99 | -300.14 | -298.32 |
Stock-Based Compensation | 102.81 | 122.88 | 263.58 | 72.69 |
Provision & Write-off of Bad Debts | 23.26 | -22.41 | -2.68 | -65.12 |
Other Operating Activities | 4,451 | 5,084 | 1,391 | 696.68 |
Change in Accounts Receivable | 3,191 | 3,825 | 558.63 | -1,117 |
Change in Inventory | -2,312 | -3,212 | -2,105 | -55.64 |
Change in Accounts Payable | -4,061 | -3,343 | 251.69 | -827.43 |
Change in Income Taxes | 5.75 | - | - | -3.98 |
Change in Other Net Operating Assets | -453.85 | -604.02 | -559.9 | -400.44 |
Operating Cash Flow | 1,237 | 2,077 | 4,385 | 2,248 |
Operating Cash Flow Growth | -66.29% | -52.64% | 95.04% | - |
Capital Expenditures | -3,373 | -3,423 | -842.32 | -1,374 |
Cash Acquisitions | 187.9 | 187.9 | - | - |
Sale (Purchase) of Intangibles | -20.75 | -8.69 | -5.83 | -3.14 |
Investment in Securities | 2,166 | 2,267 | -1,613 | -120.5 |
Other Investing Activities | -2.26 | -21.95 | - | -70 |
Investing Cash Flow | -1,114 | -1,153 | -2,161 | -1,868 |
Long-Term Debt Repaid | - | -85.93 | -137.56 | -109.02 |
Net Debt Issued (Repaid) | -85.78 | -85.93 | -137.56 | -109.02 |
Issuance of Common Stock | 263.52 | 131.66 | 672.3 | - |
Repurchase of Common Stock | -15.73 | -15.73 | - | - |
Dividends Paid | -88.86 | -285.97 | -281 | -140.5 |
Other Financing Activities | 0.45 | - | -1.02 | - |
Financing Cash Flow | 73.6 | -255.98 | 252.72 | -249.52 |
Foreign Exchange Rate Adjustments | 1.35 | 1.28 | - | - |
Miscellaneous Cash Flow Adjustments | - | - | - | -0 |
Net Cash Flow | 197.45 | 669.13 | 2,477 | 130.88 |
Free Cash Flow | -2,136 | -1,346 | 3,543 | 874.05 |
Free Cash Flow Growth | - | - | 305.32% | - |
Free Cash Flow Margin | -3.48% | -2.24% | 6.34% | 1.71% |
Free Cash Flow Per Share | -263.97 | -177.44 | 503.91 | 124.52 |
Cash Interest Paid | 10.85 | 8.99 | 12.04 | 18.36 |
Cash Income Tax Paid | 812.09 | 599.17 | 205.69 | 3.03 |
Levered Free Cash Flow | - | -2,343 | 3,382 | - |
Unlevered Free Cash Flow | - | -2,325 | 3,389 | - |
Change in Working Capital | -3,631 | -3,334 | -1,854 | -2,405 |